Cargando…
Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906818/ https://www.ncbi.nlm.nih.gov/pubmed/36755337 http://dx.doi.org/10.1186/s13046-023-02613-4 |
| _version_ | 1784884048012771328 |
|---|---|
| author | Sun, Guoliang Zhou, Hui Chen, Ke Zeng, Jin Zhang, Yangjun Yan, Libin Yao, Weimin Hu, Junhui Wang, Tao Xing, Jinchun Xiao, Kefeng Wu, Lily Ye, Zhangqun Xu, Hua |
| author_facet | Sun, Guoliang Zhou, Hui Chen, Ke Zeng, Jin Zhang, Yangjun Yan, Libin Yao, Weimin Hu, Junhui Wang, Tao Xing, Jinchun Xiao, Kefeng Wu, Lily Ye, Zhangqun Xu, Hua |
| author_sort | Sun, Guoliang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9906818 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99068182023-02-08 Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 Sun, Guoliang Zhou, Hui Chen, Ke Zeng, Jin Zhang, Yangjun Yan, Libin Yao, Weimin Hu, Junhui Wang, Tao Xing, Jinchun Xiao, Kefeng Wu, Lily Ye, Zhangqun Xu, Hua J Exp Clin Cancer Res Retraction Note BioMed Central 2023-02-08 /pmc/articles/PMC9906818/ /pubmed/36755337 http://dx.doi.org/10.1186/s13046-023-02613-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Retraction Note Sun, Guoliang Zhou, Hui Chen, Ke Zeng, Jin Zhang, Yangjun Yan, Libin Yao, Weimin Hu, Junhui Wang, Tao Xing, Jinchun Xiao, Kefeng Wu, Lily Ye, Zhangqun Xu, Hua Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 |
| title | Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 |
| title_full | Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 |
| title_fullStr | Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 |
| title_full_unstemmed | Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 |
| title_short | Retraction Note: HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 |
| title_sort | retraction note: hnrnp a1 - mediated alternative splicing of ccdc50 contributes to cancer progression of clear cell renal cell carcinoma via znf395 |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906818/ https://www.ncbi.nlm.nih.gov/pubmed/36755337 http://dx.doi.org/10.1186/s13046-023-02613-4 |
| work_keys_str_mv | AT sunguoliang retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT zhouhui retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT chenke retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT zengjin retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT zhangyangjun retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT yanlibin retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT yaoweimin retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT hujunhui retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT wangtao retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT xingjinchun retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT xiaokefeng retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT wulily retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT yezhangqun retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 AT xuhua retractionnotehnrnpa1mediatedalternativesplicingofccdc50contributestocancerprogressionofclearcellrenalcellcarcinomaviaznf395 |